Ogivri is approved for all indications of Herceptin, including for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).
from India Infoline News Service https://ift.tt/2qW1lj3
No comments:
Post a Comment